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The intradermal injection of certain bacterial products in rabbits, followed 
after a suitable interval of time by the intravenous injection of similar material, 
results in an intense hemorrhagic-necrotic  lesion at the site of the intradermal 
injection.  This phenomenon,  first described by Shwartzman (1), may also be 
produced by an intmdermal injection of a protein antigen in an appropriately 
sensitized rabbit, followed by an intravenous injection of bacterial products (2). 
Local infection with certain bacteria or with vaccinia virus also prepares  the 
skin for hemorrhagic  necrosis, which can be elicited by the subsequent  intra- 
venous injection of bacterial culture filtrates.  The phenomenon thus provides a 
useful laboratory tool for the study of immune reactions  occurring in vivo as 
well as of certain host responses to infectious agents. Numerous investigations 
of the nature of the phenomenon have been undertaken, but at the present time 
little is known of the basic mechanisms involved. 
In an earlier communication,  it was shown that a characteristic metabolic 
abnormality exists  in  rabbit  skin  sites  prepared  for  the  Shwartzman phe- 
nomenon by the intradermal injection of a meningococcal culture filtrate (3). 
This abnormality consists  of a  marked degree  of aerobic  glycolysis, with a 
consequent  local accumulation of lactic acid. It is known that such skin areas 
contain appreciable numbers of polymorphonuclear leacocytes as a result of the 
local inflammatory reaction to the bacterial filtrate (4), and it has further been 
shown  that  such  "exudate leucocytes" exhibited  a  high  degree  of  aerobic 
glycosis (5). Because of the difficulty in enumerating the inflammatory cells in 
Shwartzman-prepared  skin  sites,  however,  it  was  impossible  to  determine 
whether the over-all metabolic abnormality could be explained simply on the 
basis of the leucocyte content. 
In  1948 Becker  (6)  reported that the Shwartzman phenomenon could  be 
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prevented  by the prior treatment  of rabbits  with benzene,  nitrogen mustards, 
or x-radiation. The nature of this inhibition was not clear, and Becker assumed: 
"that  the mechanism  of suppression  by  these agents  is  exerted  through  their 
specific but  common  suppressive  action  on  the  reticulo-endothelial  system, 
primarily the vascular endothelium." However, the fact that these agents have 
in common  the property  of inducing  extreme  leucopenia  in rabbits  suggested 
further  experiments  to  determine  the  possible  role  of  leucocytes  in  the 
Shwartzman  phenomenon. 
Materials and Methods 
Rabbits.--Hybrid  male and female rabbits from the Rockefeller Institute stock were used 
throughout  the  experiments.  Animals weighing approximately  2  kilos  were  selected,  and 
lltter-mate controls were used in all experiments. In preparing the skin for intradermal in- 
jections, clippers were used to remove the hair. 
Bacterial Fittrate.--A  meningococcal "agar-washings" filtrate was kindly supplied by Dr. 
Gregory Shwartzman. This material, derived from the meningococcal strain "44B," was pre- 
pared  by  the  method  originally described  by  Shwartzman  (2).  The  skin-preparatory  dose 
used was 0.2  cc.  of a  1:2  dilution of the filtrate, injected intradermally in the right upper 
quadrant of the abdomen. The intravenous challenging dose, given into the marginal ear vein 
18 to 24 hours after the skin preparation, consisted of 2.0 cc. of a 1:25 dilution of the filtrate. 
This material, used  in  these proportions,  was sufficiently potent  to  yield strongly positive 
reactions in 100 per cent of the control animals tested. It was thus possible to work with groups 
of animals somewhat smaller than required in experiments involving the use of filtrates giving 
a lower percentage of positive reactions. 
Nitrogen  Mustard.--Methyl-bis(~-chloroethyl)amine  hydrochloride  was  kindly  sup- 
plied as "mechlorethamine hydrochloride" by Dr. Augustus Gibson of Merck and Co,, Inc., 
Rahway, New Jersey. The material was obtained in 10 rag. vials containing sufficient NaC1 to 
yiel  d an isotonic solution when 10 cc. of distilled water was added. Fresh solutions were pre- 
pared within an hour before use in each case.  This material will be hereafter referred to as 
I-IN~. 
Hematologic Studies.--Total  and  differential leucocyte counts were made  on  samples  of 
oxalated blood derived from the marginal ear veins. In most of the experiments,  these de- 
terminations were carried out daily, and  successive determinations were made at  the same 
time of each day, in order to control diurnal variations. The numbers of polymorphonuclear 
leucocytes were estimated by multiplying the total white blood cell count by the percentage 
of neutrophils obtained by the differential count of 100 leucocytes on a Wright-stained smear. 
Benzene lnjections.--A mixture of one volume of benzene and one volume of olive oil was 
prepared, and each  rabbit in the benzene series was given a daily subcutaneous injection of 
approximately 4 cc. of this mixture, amounting to 1.0 cc. of benzene per kilo of body weight. 
This procedure, originally described by Selling (7), results in a progressive leucopenia which is 
usually pronounced by the 5th day. 
Sulfonamide  Administration.--The  rabbits  receiving sulfapyridine were given two equal 
doses  of approximately 20 cc. of a 5 per cent aqueous solution of the sodium salt each day, 
calculated to give a  total daily dose of 1.0 gin. per kilo.  This material was administered by 
stomach tube at 9 a.m. and 6 p.m. each day, while the benzene was injected at 1 p.m. This 
schedule is similar to that described by McCarty and Tillett (8). 
Determination of Aerobic Glycolysis.--The  procedure  used  was  essentially  that  reported 
previously (3). Samples of prepared and normal skin were quickly removed following sacrifice CHANDLER A.  STETSON AND  ROBERT A.  GOOD  51 
of the animals. Small strips of skin, weighing approximately 100 rag., were immediately  placed 
in 25 ram. X  150 mm. test tubes containing 10 cc. portions of Krebs-Ringer solution to which 
glucose had been added to a final concentration of 200 nag. per cent. The tubes were then 
placed in a 37°C. water bath for 1 hour. An aerobic environment was maintained by bubbling 
a stream of oxygen through the solution in each tube throughout the period of incubation, this 
procedure also serving to provide adequate agitation of the suspended skin samples. At the 
end of the period of incubation, l0 cc. of l0 per cent trichloroacetic acid was added to each 
tube and the content of lactic acid was  measured by the method of Barker and Summerson 
(9) following filtration and neutralization. The weight of the tissue samples was determined 
by drying the trichloroacetic acid insoluble material to constant weight at 100°C. The degree 
of aerobic glycolysis was expressed in terms of milligrams of lactic acid produced per gram dry 
weight of tissue per hour. This technique  yielded results comparing favorably with those ob- 
tained by the method previously described  (3), in which the incubation was carried out in 
Warburg vessels. 
Histological Material.--Samples of prepared and normal skin were removed from the ab- 
domen of rabbits sacrificed by the intravenous injection of air. Imprints were made by touch- 
ing the cut edges of the tissue to clean glass slides, which were then whipped rapidly  in the air 
until dry, and stained by the Wright-Giemsa method of Downey.  Similar samples of tissue 
were dropped into l0 per cent formol-saline for fixation, then dehydrated and embedded as 
usual, sectioned at 7 m/z, and stained with hematoxylin-eosin. 
EXPERIMENTAL 
Relationship  between HN2-induced  Leucopenia  and  Inhibition  of 
the Shwartzman Phenomenon 
Preliminary experiments indicated that an intravenous dosage of 1.5  to 2.0 
nag. of HN~ per kilo of body weight was required to produce a  consistent and 
severe leucopenia in the rabbits used. This dosage is near the LDs0 reported by 
Graef et al. (10) and is in the range found by Becker (6) to be most effective in 
inhibiting the Shwartzman phenomenon.  The hematologic response to HN~ at 
this dosage level was remarkably uniform among the rabbits tested, as will be 
seen from the results of the following experiments. 
The characteristic leucopenia developing in a  rabbit given 1.75  mg. of HN2 
per kilo is illustrated in Text-fig. 1. It will be seen that the earliest demonstrable 
change in the peripheral blood is a  lymphopenia, which is most pronounced at 
18 hours. This is followed by a sharp drop in the number of circulating granulo- 
cytes, which reaches a minimum at about 90 hours.  A  complete account of the 
sequence of the hematological and  other changes following the administration 
of HN2 to rabbits is given by Graef et al. (10). 
Susceptibility to the Shwartzman Phenomenon  at Various Time Intervals  after 
the Administration of HN2.-- 
Eight rabbits were injected with 1.9 mg. of HN~ per kilo of body weight. One rabbit was 
immediately prepared for  the  Shwartzman  phenomenon,  and  the remaining rabbits were 
similarly'  prepared at 24-hour  intervals. Each rabbit was given an intravenous challenging 
injection 24 hours after the intradermal injection. Total and  differential leucocyte counts 52  POLYMORPHONUCLEAR  LEUCOCYTES  IN SIIWARTZMAN  PHENOMENON 
were made immediately prior to both the intmdermal and  the intravenous injections. The 
results of this experiment are recorded in Text-fig. 2. 
It wiLl be seen that rabbits tested before the 3rd day and after the 5th day 
foUowing the injection of HN, had an appreciable number of circulating poly- 
morphonuclear  leucocytes,  and  were  susceptible  to  the  Shwartzman  phe- 
nomenon,  while  those  tested  on  the  3rd  to  Sth  day were  found  to  have 
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TExT-Fro. 1. Hematologic changes following the administration of nitrogen mustard. The 
rabbit received an intravenous dose of HN2 amounting to 1.75 mg. per kilo of body weight. 
The circulating lymphocytes reach a low level during the first 24 hours, while the polymor- 
phonuclear leucocytes  are not significantly depressed until the 3rd day. 
negligible numbers of granulocytes and were insusceptible to the phenomenon. 
These findings confirm those of Becker (6), who noted maximal inhibition of 
the Shwartzman phenomenon on the 3rd and 4th days after injection of HN2. 
It is also indicated in Text-fig.  2  that a  reliable prediction as to the suscepti- 
bility of a given rabbit to the Shwartzman phenomenon could be made from the 
degree of erythema and induration of the prepared skin site prior to the intra- 
venous injection of bacterial filtrate.  This finding was consistent  throughout 
the following experiments, and its significance will be discussed later. 
From the results of this experiment, it is apparent that both the leucopenia CHANDLER  A.  STETSON  AND  ROBERT  A.  GOOD  53 
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TEx~roFio.  2. Susceptibility of  rabbits to  the Shwartzman phenomenon following the ad- 
ministration of nitrogen mustard. Each pair of vertical columns represents the leucocyte counts 
on a single rabbit, the blackened areas indicating the proportion of polymorphonuclear leuco- 
cytes. The column on the left in each case represents the leucocyte count at the time of the 
intradermal injection of meningococcal filtrate, while that on the right indicates the count at 
the time of the intravenous challenge, 24 hours later. 
The degree of skin preparation taking place was estimated on the basis of the amount of 
erythema, edema, and induration prior to  the intravenous  challenge, and was roughly graded 
--  to ++++.  The  intensity of  the  Shwartzman phenomenon occurring after  the  intra- 
venous challenging injection was similarly recorded, -  indicating no hemorrhage, +  indicat- 
ing scattered petechiae,  +++  indicating confluent petechiae and purpura,  and  ++++ 
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and  the  observed inhibition of  the  Shwartzman  phenomenon  are  most  pro- 
nounced  on  the  3rd  to  5th  day  following  the  administration  of HN2.  This 
time interval was therefore used throughout the remaining experiments in this 
series. 
Further Correlations  between Granulocytopenia  and Inhibition of the Shwartz- 
man Phenomenon.--Examination  of the preliminary data reported above sug- 
gested that inhibition of the Shwartzman phenomenon could be correlated with 
TABLE I 
Rdationship  between  the  Numbers  of  Circulating  Leucocytes  and  Susceptibility  to  th~ 
Shwartzman Phenomenon in Normal Rabbits and Those Treated with  Nitrogen Mustard 
HN2-treated 
Normal con- 
trois 
Total leucocytes  Polymorphonuclesr  leucocytes 
Intensity of 
Shwartzman 
phenomenon*  ."  ~ ~f°r~o  s  Beforeskm  [  "n  ve  u 
prepa~° n __1  challenge 
cdl~¢.mm.  ¢~l~¢.mm. 
3050  1600 
1865  1110 
2360  1830 
1700  1900 
2350  2350 
2550  2650 
2450  2250 
1850  1500 
8900  6300 
6850  5540 
8000  5650 
7250  6050 
4850  4120 
5620  4900 
4980  4200 
Before 
Before sk~  intravenous 
preparation  challenge 
celiac.ram.  ¢dl$/c.mm. 
335  176 
252  55 
189  308 
987  560 
94  125 
153  123 
270  20 
980  87 
3920  3020 
3770  1380 
4160  1070 
5200  3950 
2800  2380 
3100  2180 
4100  3250 
m 
w 
++++ 
++++ 
++++ 
++++ 
++÷+ 
÷+++ 
÷÷+÷ 
* +÷÷+  indicates a  strongly positive hemorrhagic-necrotic  reaction occurring  at  the 
site of the intradermal injection within 4 hours after the intravenous challenging injection; 
-- indicates the complete absence of any petechial or hemorrhagic reaction at the site of the 
intradermal injection during the 24 hours subsequent to the intravenous challenge. 
a  reduction in the  number  of circulating granulocytes, rather  than  with  the 
numbers of lymphocytes. This concept was adopted as a  working hypothesis, 
and further experiments were designed to test its validity. 
The following experiment was designed to test the reproducibility with which 
HN2 produced inhibition of the Shwartzman phenomenon. 
Eight rabbits were given intravenous injections of HN2 in a dose of 1.75 mg. per kilo, and 
daily total and differential leucocyte counts were made on these and on seven control animals. 
4 days after the injection of HN2, at a time when all the test animals showed an extreme leuco- CHANDLER A.  STETSON AND ROBERT A.  GOOD  55 
pelda, intradermal  injections of the meningococcal filtrate were made in all fifteen animals, 
and 24 hours later all animals were challenged intravenously.  The results of this experiment 
can be seen in Table I. 
All the control animals  developed typical strong reactions,  while  the HN2- 
treated  animals  were completely negative.  These  data  illustrate  the  uniform 
correlation between  granulocytopenia and  inhibition  of the Shwartzman phe- 
nomenon which was observed throughout the present study. 
Rabbits  treated with HN2 develop manifestations  of a  general intoxication, 
and exhibit pathological changes in several organs (I0). These systemic effects 
do not appear  to be  dependent  on the  damage to the bone marrow,  and the 
resulting leucopenia. Therefore an attempt was made to determine whether any 
effects other than the granulocytopenia might be responsible for the observed 
inhibition  of the  Shwartzman phenomenon.  Use was made  of a  technique  in 
which the femoral marrow of rabbits is protected against the damaging effects 
of HN2 by clamping the abdominal aorta while HN2 is injected into the marginal 
ear  vein.  Karnofsky  d  al.  (II)  have  shown  that  under  these  conditions  the 
injected HN2 is rapidly fixed in that portion of the animal's body supplied  by 
the aorta proximal to the clamp. This procedure effectively spares the femoral 
marrow from the characteristic degenerative and atrophic changes induced by 
HN2, and this marrow is sufficient to provide nearly normal numbers of circular- 
hag leucocytes.  Rabbits  so treated  exhibited  the  usual  degree of systemic re- 
action to the HN2, with lymphatic atrophy, neurologic damage, and lesions of 
the gastrointestinal tract, but did not show the usual granulocytopenia. 
For these experiments rabbits  were anaesthetized  with nembutal,  laparotomy  was per- 
formed, and an arterial  damp was applied to the abdominal aorta below the level of the in- 
ferior mesenteric artery.  In alternate  animals, designated "protected," HN~ in a dose of 1.75 
rag. per kilo was injected into the marginal ear vein after the clamp had been applied, and 
the clamp was left in place for 5 minutes after the injection  was completed. In the remaining 
animals, designated "sham-operated,"  the clamp was allowed to remain in place for 5 minutes, 
then removed, and the injection of HN2 was made after circulation to the lower extremities 
had been reestablished. These latter animals thus served as controls on the possible effects of 
the marrow anoxia as well as of the operative trauma. 
Four days after the injection of HN~ the animals were given preparatory skin injections of 
meningococcal filtrate,  and 24 hours later  intravenous  challenging injections were made in 
each rabbit.  Leucocyte counts were made before the intradermal  and intravenous injections, 
and the degree of erythema  and induration  of the prepared  skin site was noted  before the 
intravenous injection of bacterial filtrate. 
In Table II are recorded the results of one such experiment. It can be seen 
that each of the three sham-operated animals developed the expected granulo- 
cytopenia and was insusceptible to the Shwartzman phenomenon. In contrast, 
the four "protected" animals retained essentially normal numbers of granu- 
locytes, and each of these animals developed a  typical hemorrhagic necrotic 
Shwartzman reaction. This experiment indicates  that the systemic effects of 56  POLYMORPIIONUCLEAR  LEUCOCYTES  IN  SHWARTZMAN  PHENOMENON 
HN2 intoxication,  including  possible  effects  on  the vascular endothelium  as 
suggested by Becket (6), apparently play no role in the observed inhibition  of 
the  Shwartzman  phenomenon.  Protection  of a  portion  of  the bone marrow 
against HN2 suffices to overcome this inhibition,  and this effect appears to be 
correlated with the persistence of circulating  polymorphonuclear leucocytes. 
Correlation Between the  Histologic Appearance  of Prepared Skin  and  the 
Granulocytopenia Induced by HN2.--In order to secure further evidence bearing 
on the working hypothesis that polymorphonuclear leucocytes may be impli- 
cated in the Shwartzman phenomenon, it was necessary to attempt to correlate 
the number of these cells in the circulation with their appearance in the inter- 
TABLE  II 
Susceptibility  to the Shwartzman  Phenomenon,  Following Treatment  with HN2, of Rabbits  in 
Which the Femoral Marrow Had Been Protected against the HN~ 
"Protected" 
rabbits 
Sham-oper- 
ated rab- 
bits 
 bbit 
Total leucocytes  Polymorphonuchar leucocytes 
Intensity of 
Shwartzman 
phenomeno~*  Before skin  Before  intravenous 
preparation  challenge 
¢ells/¢.mm.  cdls/¢.mm. 
6600  8550 
6850  4550 
5500  3550 
49O0  640O 
4250  3650 
2110  2550 
3600  3750 
Before skin  Before 
preparation  intravenous  challenge 
¢.dls/¢.mm.  etlls/¢.mm. 
3300  2140 
5150  2880 
4350  2130 
2690  3200 
340  73 
21  51 
410  211 
++++ 
++++ 
++++ 
++++ 
* ++++  indicates development of a  typical hemorrhagic-necrotic skin lesion following 
the intravenous challenge; -- indicates absence of any hemorrhagic-necrotic reaction follow- 
ing the intravenous challenge. 
stitlal  inflammatory  exudate  called  forth  by  the  intradermal  injection  of 
meningococcal  filtrate.  For  this  purpose,  the  following  experiment  was 
carried out. 
Four rabbits were given intravenous injections of 1.75 rag. I-IN~ per kilo. 4 days later, these 
and four normal control rabbits were given preparatory doses of meningococcal filtrate intra- 
dermally.  24 hours later,  at  a  time when  the  control rabbits were  fully prepared for the 
Shwartzman phenomenon, all were  sacrificed.  Samples of  prepared and normal skin were 
quickly removed from each animal, and histological preparations were made as previously de- 
scribed. Leucocyte counts were  repeated  shortly before sacrifice. The results of this experi- 
ment are summarized in Table III. 
The HN2-treated rabbits all had pronounced leucopenla,  with virtually no 
circulating granulocytes, throughout the period of skin preparation. This state 
of affairs was paralleled by an almost complete absence of granulocytes from CHANDLER  A.  STETSON  AND  ROBERT  A.  GOOD  57 
the  prepared skin  areas.  Microscopic examination of the  imprints  prepared 
directly from the fresh tissue  showed no polymorphonuclear leucocytes, and 
study of the formalin-fixed sections revealed only an occasional neutrophil. The 
control  rabbits,  however,  had  normal  numbers  of  circulating  polymorpho- 
nuclear leucocytes, and prepared skin areas from these animals showed a heavy 
infiltration with  granulocytes.  The pronounced contrast  in  the  microscopic 
appearance  of prepared  skin  sites  from normal  and  HNrtreated  animals  is 
illustrated in Figs. 1-6. 
These results strongly suggest that an essential feature of the Shwartzman 
phenomenon  is  a  local  accumulation  of  polymorphonuclear leucocytes. In 
TABLE  III 
Relationship  between the Number of Circulating Leucocytes and the Occurrence of L~ocytes in 
Pre Oared Skin Sites in Normal and HNrTreated Rabbits 
HNrtreated 
rabbits 
Normal con- 
trois 
~.bl~ 
No. 
5 
6 
7 
8 
Total leucocytes  Polymorphonuclear  leucocytes  Leucocytes 
in prepared 
ekm site*  Before skin  Before  mcritice 
prep&ratinn 
cdls/c.mra,  cdls/¢.mra. 
2800  1650 
2500  1500 
2700  2400 
2750  1900 
10900  12500 
11200  11850 
10350  10700 
10450  11550 
Before skin  Before  sacrifice  prepsration 
cdJs/¢.fm,  tdls/c.mm. 
0  0 
0  0 
27  0 
0  19 
8250  3250 
4480  4250 
52O0  5700 
4300  5200 
-4- 
.-4- 
++++ 
++++ 
++++ 
++++ 
* ++++  indicates a heavy infiltration with leucocytes, with polymorphonuclear  neu- 
trophils predominating; -4-  indicates that only occasional polymorphonudear leucocytes 
were found, and that the cellular infiltration was minimal in degree; -- indicates the absence 
of leucocytic infiltration. 
rabbits  treated with  HN~,  these ceils are present  in  the  circulation only in 
extremely small  numbers.  The intradermal  injection of bacterial  filtrate in 
these rabbits  is not followed by the  appearance of such  cells at the  site of 
injection, and in the absence of these cells the tissue does not exhibit the charac- 
teristic hemorrhagic-necrotic reaction to intravenously injected meningococcal 
filtrate. 
Aerobic Glycolysis of Prepared and Normal Skin from HN~-Treated Rabbits.~ 
It was of interest to determine whether the characteristic metabolic abnormality 
of prepared skin reported earlier (3) would develop in rabbits that had been 
previously treated with HN2. To provide an answer to this question, determina- 
tions of aerobic glycolysis were carried out on samples of prepared and normal 58  POLYMORPHONUCLEAR  LEUCOCYTES  IN" SHWARTZMAN  PIKENOMENON 
skin obtained  from the  same  rabbits  described  in the  preceding  experiment. 
The results obtained,  illustrated  in Text-fig. 3, may therefore be considered in 
the light of the histologic and hematologic data recorded in Table III. 
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• T~xr-Fio. 3. Aerobic glycolysis of normal and prepared skin from HN~-treated and normal 
rabbits. Each pair of vertical columns represents the aerobic lactic acid production by samples 
of normal (unshaded columns) and prepared skin (blackened columns) from a single rabbit. 
Rabbits 1 to 4, inclusive, had received HN~ 4 days previously. Rabbits 5 to 8, inclusive, served 
as~ normal controls. Hematologic data on these rabbits appears in Table III. 
The normal rabbits'  prepared skin samples exhibit a characteristic  high degree of aerobic 
glycolysis, the values being approximately  fivefold higher than those for normal skin. The 
HN2-treated rabbits  exhibit the same phenomenon although  to a much less degree, the pre- 
pared skin samples producing only twice as much lactic acid as the control samples of normal 
skin. 
The degree of aerobic glycolysis found in the samples of prepared skin from 
the normal control rabbits was significantly elevated above that found in the 
samples  of normal skin  from the  same animals,  and  the  values  in each  case 
agree well with those previously reported  (3).  In the case of the HN2-treated 
animals,  some  increase  in aerobic  glycolysis was found in  the  prepared  skin CHANDLER  A.  STETSON  AND  ROBERT  A.  GOOD  59 
sites. This increase was consistent, but was of a  considerably less degree than 
that found in the prepared skin samples from the normal control animals. 
Correlation  between  Benzene-Induced  Leucopenia  and  Inhibition  of  the 
Strwartzman Phenomenon 
The work of McCarty and Tillett (8) indicates that the well known leucopenic 
effect  of repeated benzene  injections in  rabbits  can  be  counteracted  by  the 
simultaneous administration of sulfapyridine. The mechanism of this antago- 
TABLE IV 
Leucocyte Counts  and  Susceptibility  to  the  Shwartzman  Phenomenon  in  Rabbits Recei'dng 
Daily Inj~tions of Benzene 
Rabbit  Treatment 
No. 
0 
1  2980 
2.  5190 
3  3180 
4  5390  Benzene  5  2690 
6  1930 
7  3300 
8  2900 
9  Benzene  6225 
10  and sul-  t 5520 
11  fapyri- ] 3860 
12  dine  6350 
13  5490 
Polymorphonuclear leucocytes 
Days after beginning  benzene injections 
I  2  3  4  S  6  7 
1995 
4130 
3880 
6200 
3500 
5200 
2980 
2200 
5400 
6400 
6020 
5250 
6100 
1690 
2760 
3390 
7450 
4i50 
8760 
4860 
5400 
10200 
7220. 
3600 
9650 
735 
2600 
655 
920 
6600 
4500 
9280 
5040 
5100 
12300 
6850 
8900 
10280 
dead 
2ooo~ 
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*-- indicates that no hemorrhagic  skin reaction appeared in this rabbit following the 
intravenous challenge; +++  indicates the development of confluent peteehial and hemor- 
rhagic lesions at the site of the intradermal injection following the intravenous challenge; 
++++  indicates a maximal hemorrhagic-necrotic  skin reaction following ~e intravenous 
challenge. 
:~ indicates that an intradermal injection of meningococcal filtrate was made immediately 
following this bleeding. 
§ indicates that an intravenous challenging  injection was  made immediately following 
this bleeding. 
nism is not known. There is some evidence that the sulfonamide alters certain 
of the metabolic effects of benzene  intoxication,  with a  consequent reduction 
in mortality. This effect of sulfapyridine, however, is of considerably less degree 
than  the  antileucopenic action,  and  it  seemed  possible that  the  use  of  this 
drug might offer the same sort of control over the systemic intoxication that 60  POLYMORPHONUCLEAR  LEUCOCYTES  IN SHWARTZMAN  PHENOMENON 
was afforded by the clamping technique in the case of the experiments involving 
the use of HN2. 
In the following experiment, thirteen rabbits were used. Eight rabbits received benzene 
alone, and five rabbits received benzene and sulfapyridine,  as described above. 4 to 6 days 
after the benzene  injections  were  begun, the rabbits were  prepared by the intradermal injection 
of meningococcal  filtrate, and 24 hours later each  was given an intravenous challenging dose. 
The results of this experiment are included in Table IV. 
While these results are more difficult to interpret than those obtained with 
I-IN2, because of the mortality and the inconsistent degree of leucopenia within 
each group, there is nevertheless a  significant correlation between the degree 
of  granulocytopenia  in  each  rabbit  and  the  subsequent  reactivity  to  the 
Shwartzman phenomenon.  It will be seen that  no rabbit  with  a  circulating 
polymorphonuclear leucocyte count lower than 1200 ceils per c.mm. at the time 
of intravenous challenge subsequently developed a  positive  Shwartzman  re- 
action, while all five animals having a count of 1500 granulocytes per c.mm. or 
more showed positive  reactions.  The failure of  two  of the rabbits receiving 
benzene alone to develop satisfactory leucopenia may be due to the fact that 
the experiment was  terminated at a  time when benzene had been given for 
only 6  days. The results obtained by McCarty and Tillett  (8)  suggest  that 
treatment for a somewhat longer period may be necessary to produce a uniform 
leucopenia. It should be pointed out, moreover, that the observed variations 
in circulating leucocyte counts are actually helpful in determining the critical 
level of granulocytes, below which inhibition of the Shwartzman phenomenon 
occurs. 
DISCUSSION 
The intradermal injection of a bacterial filtrate of the type employed in the 
present study is followed by a  visible local inflammatory reaction, character- 
ized by erythema, edema, and induration. This primary reaction is usually well 
established 24 hours after the intradermal  injection. In rabbits receiving no 
further  treatment,  this  local  inflammatory  reaction  gradually  subsides.  If, 
however, an additional injection of the bacterial filtrate is given intravenously 
24 hours after the intradermal injection, a pronounced reaction occurs at the 
site of the intradermal injection. Within 2  to 4  hours petechiae appear,  and 
these increase in number and size until the entire area is occupied by an intense 
hemorrhagic necrotic lesion. Histologically this lesion is characterized by dis- 
integration of the polymorphonuclear leucocytes which had appeared in the 
tissue during the period of skin preparation, thrombosis and disruption of many 
of the small blood vessels, and extensive hemorrhage. These and other features 
of the phenomenon are discussed at length by Shwartzman (2). 
Diverse opinions have been expressed in the past regarding the significance 
of the primary inflammatory reaction described above. Opie (12), Menkin (13), CHANDLER  A.  STETSON  AND  ROBERT  A.  GOOD  61 
and  Karsner and  Moritz  (4)  were of the opinion  that  this primary reaction 
played an essential role in the subsequent hemorrhagic necrosis of the Shwartz- 
man phenomenon,  perhaps  by inducing  a  local accumulation of the intrave- 
nously injected "challenging" bacterial products. In opposing this point of view, 
Shwartzman  (2) pointed out that skin sites injected with any of several non- 
bacterial products capable of producing local inflammation  do not react with 
hemorrhagic necrosis  to the subsequent injection of potent bacterial filtrates, 
indicating that local inflammation  per se does not necessarily constitute prepa- 
ration for the phenomenon. Similarly,  Gerber (14) was unable to demonstrate 
a  relationship  between the intensity of the primary skin reaction to various 
bacterial  filtrates  and  the  subsequent  reactivity  of  such  skin  sites  to  the 
Shwartzman phenomenon. 
In a previous study (3), evidence was presented to support the concept that 
an essential feature of skin preparation for the Shwartzman phenomenon is the 
development of conditions favoring the local action of intracellular proteolytic 
enzymes,  or  "cathepsins."  Such  conditions  include  a  lowering  of  the  local 
redox potential and the occurrence of aerobic glycolysis, with the accumulation 
of lactic acid in the tissue and a local fall in pH. It was suggested  that such 
conditions might  be brought about either by a  direct action of the bacterial 
products on epithelial elements or by a secondary effect on the formed elements 
of  the  interstitial  inflammatory  exudate  which  appears  in  such  skin  areas. 
The latter possibility was made more likely by the observation that  no de- 
tectable alteration  of glycolysis  occurs in  vitro when samples of normal  skin 
are exposed directly to the meningococcal  filtrate, suggesting  that the observed 
metabolic derangement  in prepared  skin areas is due to the arrival  in these 
areas of new metabolizing elements. 
The present experiments bear directly on this problem, and strongly support 
the hypothesis that  the initial inflammatory response is essential  to the sub- 
sequent development of the Shwartzman phenomenon.  When the number of 
circulating leucocytes is sufficiently depressed by the administration of nitrogen 
mustard,  no evidence of inflammation following  the intradermal  injection of 
meningococcal  filtrate is  apparent  either in  the  gross or histologicaUy.  Such 
injected skin sites do not exhibit the  high  degree  of  aerobic  glycolysis  seen 
in prepared skin samples from normal control rabbits, and do not respond with 
hemorrhagic  necrosis  to  intravenously  injected  bacterial  filtrate.  In  control 
rabbits protected against the leucopenic  but not the systemic effects of HN~, 
normal numbers of leucocytes persist in the circulation and adequate prepara- 
tion for the Shwartzrnan  phenomenon can occur. Similarly,  the inhibition of 
the Shwartzman  phenomenon by repeated administration  of benzene can be 
correlated with  the leucopenia produced by this  agent,  and  such  inhibition 
does not occur in rabbits protected against this leucopenia by the simultaneous 
administration  of sulfapyridine. 
These experiments, viewed in the light of data obtained by Karnofsky et al. 62  POLYMORPHONUCLEAR  LEUCOCYTES  IN  SHWARTZMAN  PHENOMENON 
(11), permit the further conclusion that the actual cells involved in this phe. 
nomenon are  the  polymorphonuclear  leucocytes.  These  cells persist  in  the 
circulation  in nearly normal numbers until after the 3rd day following  the 
administration of HN~,  and it has been shown that HN2-treated  ~abbits are 
susceptible  to the Shwartzman phenomenon until this time. No inhibition of 
the Shwartzman phenomenon  can be demonstrated during the 1st day after 
the injection  of HN~, at a  time when the circulating  lymphocytes are most 
severely  depressed.  Susceptibility  to  the  Shwartzman phenomenon  returns 
after the 5th day following HN~-treatment,  and can be correlated  with the 
reappearance  of polymorphonuclear leucocytes in the circulation as the marrow 
regenerates.  No  significant  differences in lymphocyte counts were  observed 
between those  animals in which  the femoral  marrow was protected against 
HN2 and those  which  received HN2 without such protection, while striking 
and consistent differences in granulocyte counts were found and could again 
be  correlated  with  susceptibility  to  the  Shwartzman phenomenon.  Finally, 
abundant evidence has been obtained by other authors (2) that a characteristic 
histologic feature of the inflammatory  reaction in skin prepared for the Shwartz- 
man phenomenon  is  the interstitial and perivascular  accumulation of poly- 
morphonuclear  leucocytes. 
A constant finding throughout this study was the almost complete absence 
of visible  erythema and  induration following  the  intradermal  injection  of 
meningococcal filtrate in those  animals  in which  the number of circulating 
granulocytes had been reduced to a low level. This was the case in experiments 
in which  the leucopenia had been  produced  by benzene  as well as in those 
involving the use of HN2. As previously stated, it was uniformly possible to 
predict with considerable accuracy from the appearance  of such an injected 
skin  site  prior to  the  intravenous  "challenging" injection whether  or  not 
hemorrhagic necrosis would subsequently develop. The theoretical implications 
of this observation may be of considerable importance.  It is possible that the 
features by which a prepared skin area may be recognized in the gross, namely, 
erythema, edema, and induration, may all be secondary phenomena, depending 
on and determined by the presence of polymorphonuclear  leucocytes in such 
tissue. If, as seems likely from the data now available, such exudate leucocytes 
account for the  observed  aerobic  glycolysis in such  tissue,  the well known 
capacity of lactic acid to produce vasodilation may well be the explanation for 
the occurrence  of these  secondary  phenomena in this type of inflammatory 
response, and perhaps in others. 
SUMMARY 
The inhibition of the Shwartzman phenomenon by nitrogen mustard and 
benzene has been confirmed and investigated further. 
This  inhibition can  be  correlated with  the  leucopenia  induced by  these 
agents, CHANDLER  A. STETSON AND  ROBERT  A. GOOD  63 
Evidence is presented  indicating that  polymorphonuclear leucocytes play 
an essential role in the preparation of the skin for the Shwartzman phenomenon. 
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EXPLANATION OF PLATE 2 
The histologic appearance  of skin prepared for the  Shwaxtzman phenomenon in 
normal and in HNrtreated rabbits. 
All skin samples were  fixed in formol-saline and stained  with hematoxylin-eosin. 
FIG. 1.  Skin from abdomen of a normal rabbit (Rabbit 5 of Table III). ×  46. 
FIG. 2.  Higher magnification of same, showing absence of leucocytes in subcuta- 
neous tissue.  ×270. 
FIG. 3.  Skin area prepared for the Shwartzman phenomenon by the intradermal 
injection of meningococcal filtrate 24 hours previously, from a normal rabbit (Rabbit 
5 of Table III), showing the intense interstitial inflammatory exudate.  X46. 
FI6. 4.  Higher magnification of skin area shown in Fig. 3, illustrating the edema 
and the character of the exudate, which consists predominantly of polymorphonuclear 
leucocytes. ×270. 
FIG. 5.  Skin area injected 24 hours previously with meningococcal filtrate, from a 
rabbit treated with HN~ (Rabbit 1 of Table III).  ×46. 
FIG. 6.  Higher magnification of skin area shown in Fig. 5, illustrating the preser- 
vation of normal architecture,  the absence of edema and  the absence of leucocytic 
infiltration. No polymorphonuclear leucocytes could be found in these sections.  X270. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 93  PLATE  2 
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